tiprankstipranks

Biotech Spectator Profile - Seeking Alpha Blogger

4 Followers
tipranks
Biotech Spectator

Biotech Spectator
Seeking Alpha

Financial Blogger
#6,884 out of 28,681 Financial Bloggers
#11,131 out of 37,481 experts

Success Rate

50%
3 out of 6 ratings made a profit

Average Return

+9.30%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Biotech Spectator's trades since 2020 and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of 9.3% per rating.

Stock Rating Distribution

6Ratings
100.00% Bullish
0.00% Neutral
0.00% Bearish
Distribution of Biotech Spectator's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Catalyst Pharmaceutical Partners
(CPRX)
Rating:Buy
Date:Dec 30, 2020 - Dec 30, 2021
Return:+101.40%
The most profitable rating made by Biotech Spectator

Biotech Spectator's Stock Coverage

Company Name
Date
Position
No. of Ratings
Success Rate
Avg Return
Roku
Dec 15, 2020
Bullish
1Ratings
0%
-36.20%
Vericel
Dec 18, 2020
Bullish
1Ratings
100%
+52.20%
Catalyst Pharma
Dec 30, 2020
Bullish
2Ratings
100%
+77.55%
Omeros
Feb 10, 2021
Bullish
2Ratings
0%
-57.65%
List of latest recommendations made by Biotech Spectator. Click to expand and see Biotech Spectator's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.